search
Back to results

Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells

Primary Purpose

Liver Cirrhosis

Status
Terminated
Phase
Phase 1
Locations
Japan
Study Type
Interventional
Intervention
adipose tissue derived stromal cells
Sponsored by
Kanazawa University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Liver Cirrhosis focused on measuring Liver Cirrhosis

Eligibility Criteria

20 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Liver cirrhosis patients
  • Platelets count in peripheral blood: over 7.0x10^4/microliter
  • Serum creatinine: less than 1.5 mg/dl
  • Capable of understanding the features of this clinical trial

Exclusion Criteria:

  • Associated with risky gastroesophageal varices for bleeding
  • Severe portal hypertension
  • Complicated with severe heart failure
  • Renal disease
  • Respiratory disease
  • Hematological disease
  • Coagulation disturbance and judged to be excluded by doctors
  • Associated with malignancy
  • Past history of the following:

    • malignancy
    • ischemic heart disease
    • cerebrovascular disease (cerebral infarction, cerebral hemorrhage)
    • decompensated status of liver cirrhosis
  • Pregnant, or possibility of pregnancy
  • Infected with HIV
  • Under mediation with adrenal corticoid steroid, anti-histamine drug
  • Anticipated with difficulty of follow-up observation
  • Anticipated with inconsistency of following the protocol
  • Addiction of alcohol drinking and unable to stop drinking
  • Other candidates who are judged to be not applicable to this study by doctors

Sites / Locations

  • Kanazawa University Hospital

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

adipose tissue derived stromal cells

Arm Description

Outcomes

Primary Outcome Measures

all cause harmful events

Secondary Outcome Measures

Full Information

First Posted
June 3, 2009
Last Updated
October 16, 2012
Sponsor
Kanazawa University
search

1. Study Identification

Unique Protocol Identification Number
NCT00913289
Brief Title
Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells
Official Title
Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells
Study Type
Interventional

2. Study Status

Record Verification Date
October 2012
Overall Recruitment Status
Terminated
Study Start Date
February 2009 (undefined)
Primary Completion Date
April 2010 (Actual)
Study Completion Date
April 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Kanazawa University

4. Oversight

5. Study Description

Brief Summary
Mesenchymal stem cells have the capability to differentiate into hepatocytes and will be useful for liver regeneration. Adipose tissue is relatively enriched with mesenchymal stem cells compared to bone marrow tissue. In this trial, eligible liver cirrhosis patients will receive autologous adipose tissue derived stromal cells which include such mesenchymal stem cells.
Detailed Description
The population of the liver cirrhosis patients is enormous in Japan and the only radical treatment for them is liver transplantation. However, the number of giving donors is extremely limited. Mesenchymal stem cells have been capable to differentiate into mesodermal-lineage cells as well as endodermal-lineage cells such as hepatocytes. They reside in the mesenchymal tissues such as bone marrows as well as adipose tissues. The latter tissues are relatively enriched with mesenchymal stem cells compared to bone marrow cells. In this study, the cirrhotic patients will receive autologous adipose tissue derived stromal cells which contains substantial number of mesenchymal stem cells.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Cirrhosis
Keywords
Liver Cirrhosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
6 (Actual)

8. Arms, Groups, and Interventions

Arm Title
adipose tissue derived stromal cells
Arm Type
Other
Intervention Type
Biological
Intervention Name(s)
adipose tissue derived stromal cells
Intervention Description
dosage
Primary Outcome Measure Information:
Title
all cause harmful events
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Liver cirrhosis patients Platelets count in peripheral blood: over 7.0x10^4/microliter Serum creatinine: less than 1.5 mg/dl Capable of understanding the features of this clinical trial Exclusion Criteria: Associated with risky gastroesophageal varices for bleeding Severe portal hypertension Complicated with severe heart failure Renal disease Respiratory disease Hematological disease Coagulation disturbance and judged to be excluded by doctors Associated with malignancy Past history of the following: malignancy ischemic heart disease cerebrovascular disease (cerebral infarction, cerebral hemorrhage) decompensated status of liver cirrhosis Pregnant, or possibility of pregnancy Infected with HIV Under mediation with adrenal corticoid steroid, anti-histamine drug Anticipated with difficulty of follow-up observation Anticipated with inconsistency of following the protocol Addiction of alcohol drinking and unable to stop drinking Other candidates who are judged to be not applicable to this study by doctors
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Shuichi Kaneko, M.D.
Organizational Affiliation
Kanazawa University
Official's Role
Study Chair
Facility Information:
Facility Name
Kanazawa University Hospital
City
Kanazawa
State/Province
Ishikawa
ZIP/Postal Code
920-8641
Country
Japan

12. IPD Sharing Statement

Learn more about this trial

Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells

We'll reach out to this number within 24 hrs